BREAKING: FDA Moves PLX cell COVID-19 Treatment With 100% Survival Rate Into Clinical Trials

One Israeli company has created a treatment for the Wuhan Coronavirus that has thus far proved to be 100 percent effective in treating the virus.

According to the Jerusalem Post, the company Pluristem created a placenta-based cell-therapy ..

...Four of the (COVID19) patients also demonstrated failure of other organ systems, including cardiovascular and kidney failure.
Not only have all the patients survived.. but four of them showed improvement in respiratory parameters..

the PLX cells .. harness our own immune system’s regulatory T cells and M2 macrophages to prevent overactivation of the immune system. This helps us avoid the symptoms of pneumonia and pneumonitis from becoming fatal...

[link to www.redstate.com (secure)]

Last Edited by DeploraVision ™ on 04/10/2020 10:58 PM